Welch Daniel G

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Welch Daniel G
CIK #0001206199
EDGAR Form CIK 2011 - 2026
3 [0001206199]
4 [0001206199]
5 [0001206199]
Form 3/4/5 Subject 2011 - 2026
Welch Daniel G
Structure Therapeutics Inc
Ultragenyx Pharmaceutical Inc
Prothena Corp Public Ltd Co
Panacea Acquisition Corp
Seattle Genetics Inc /WA
Intercept Pharmaceuticals Inc
AveXis Inc
Hyperion Therapeutics Inc
Intermune Inc
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Structure Therapeutics Inc GPCR
Share Option (right to buy) · derivative
2025-06-23 Grant 51,804 $0.00
Ultragenyx Pharmaceutical Inc RARE
Common Stock
2025-05-15 Grant 5,740 $0.00
Ultragenyx Pharmaceutical Inc RARE
Stock Option (Right to Buy) · derivative
2025-05-15 Grant 10,787 $0.00
Prothena Corp Public Ltd Co PRTA
Stock Option (Right to Buy) · derivative
2025-05-14 Grant 20,183 $0.00
Structure Therapeutics Inc GPCR
Share Option (right to buy) · derivative
2024-06-25 Grant 37,500 $0.00
Ultragenyx Pharmaceutical Inc RARE
Common Stock
2024-06-18 Grant 5,345 $0.00
Ultragenyx Pharmaceutical Inc RARE
Stock Option (Right to Buy) · derivative
2024-06-18 Grant 9,900 $0.00
Panacea Acquisition Corp NUVB
Stock Option (Right to Buy) · derivative
2024-05-24 Option exercise 293,203 $0.00
Panacea Acquisition Corp NUVB
Class A Common Stock
2024-05-24 Option exercise 366,744 $1.64 601,460
Panacea Acquisition Corp NUVB
Class A Common Stock
2024-05-24 Option exercise 293,203 $1.74 510,173
Panacea Acquisition Corp NUVB
Stock Option (Right to Buy) · derivative
2024-05-24 Option exercise 366,744 $0.00
Prothena Corp Public Ltd Co PRTA
Stock Option (Right to Buy) · derivative
2024-05-15 Grant 15,000 $0.00
Prothena Corp Public Ltd Co PRTA
Stock Option (Right to Buy) · derivative
2024-02-21 Grant 132,000 $0.00
Seattle Genetics Inc /WA SGEN
Common Stock
2023-12-14 Disposed to issuer 10,725 $229.00 2,456,025
Seattle Genetics Inc /WA SGEN
Common Stock
2023-12-14 Disposed to issuer 4,750 $229.00 1,087,750
Seattle Genetics Inc /WA SGEN
Restricted Stock Units · derivative
2023-12-14 Disposed to issuer 2,044
Seattle Genetics Inc /WA SGEN
Non-Qualified Stock Option (right to buy) · derivative
2023-08-28 Option exercise 1,812 $0.00
Seattle Genetics Inc /WA SGEN
Common Stock
2023-08-28 Sell 1,610 $209.08 336,619
Seattle Genetics Inc /WA SGEN
Common Stock
2023-08-28 Option exercise 1,812 $135.63 245,762
Seattle Genetics Inc /WA SGEN
Common Stock
2023-08-28 Sell 1,812 $209.01 378,726
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com